Skip to main content

JPMORGAN CHASE & CO

Position in ROIV — Roivant Sciences Ltd.

CIK 19617 NEW YORK, NY

Position in ROIV

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$40,269,110
-$2,320,164 QoQ
Shares Held
1,137,867
-26.0% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 494 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 44% Shared 0% None 56%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. ROIV ranks #37 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ROIV

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,269,110 1,137,867
2026-03-31 $42,589,274 1,537,519
2025-12-31 $20,279,364 934,533
2025-09-30 $18,597,749 1,229,197
2025-06-30 $8,834,855 783,927
2025-03-31 $8,150,347 807,765
2024-12-31 $9,091,223 768,489
2024-09-30 $9,492,594 822,582
2024-06-30 $8,330,521 788,129
2024-03-31 $9,736,870 923,802
2023-12-31 $4,743,999 422,440
2023-09-30 $6,647,319 569,120
2023-06-30 $3,334,632 330,817
2023-03-31 $2,514,792 340,758
2022-12-31 $593,608 74,294
2022-09-30 $131,247 40,760
2022-06-30 $154,228 37,894